These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
783 related items for PubMed ID: 18164881
21. Polymyxin B: similarities to and differences from colistin (polymyxin E). Kwa A, Kasiakou SK, Tam VH, Falagas ME. Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915 [Abstract] [Full Text] [Related]
22. In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate. Desai TR, Tyrrell GJ, Ng T, Finlay WH. Pharm Res; 2003 Mar; 20(3):442-7. PubMed ID: 12669966 [Abstract] [Full Text] [Related]
23. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A. Antimicrob Agents Chemother; 2006 Jun; 50(6):2016-22. PubMed ID: 16723560 [Abstract] [Full Text] [Related]
24. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa. Abraham N, Kwon DH. FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916 [Abstract] [Full Text] [Related]
32. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Hussein MH, Schneider EK, Elliott AG, Han M, Reyes-Ortega F, Morris F, Blastovich MAT, Jasim R, Currie B, Mayo M, Baker M, Cooper MA, Li J, Velkov T. Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770 [Abstract] [Full Text] [Related]
33. Treatment of experimental osteomyelitis by liposomal antibiotics. Kadry AA, Al-Suwayeh SA, Abd-Allah AR, Bayomi MA. J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079 [Abstract] [Full Text] [Related]
34. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Tré-Hardy M, Vanderbist F, Traore H, Devleeschouwer MJ. Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117 [Abstract] [Full Text] [Related]
35. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO, Omri A. Int J Pharm; 2009 May 21; 373(1-2):141-6. PubMed ID: 19429299 [Abstract] [Full Text] [Related]
36. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. Khan MA, Owais M. J Antimicrob Chemother; 2006 Jul 21; 58(1):125-32. PubMed ID: 16709592 [Abstract] [Full Text] [Related]